Evidence map›Paper›PMID 20820630›Full record

ArticleIntegrative biology : quantitative biosciences from nano to macro2010

Multiplexed, high-throughput analysis of 3D microtissue suspensions.

Alice A Chen, Gregory H Underhill, Sangeeta N Bhatia

Abstract read
In one paragraph

Article in Integrative biology : quantitative biosciences from nano to macro, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Noninvasive andThe Analyst · 2025
    Article
  2. Review
  3. Article
  4. Organotypic Modeling of the Tumor Landscape.Frontiers in cell and developmental biology · 2020
    Review
  5. Article
  6. The Role of Microfluidics for Organ on Chip Simulations.Bioengineering (Basel, Switzerland) · 2017
    Review
  7. Article
  8. Article
  9. Review
  10. Microfluidic organs-on-chips.Nature biotechnology · 2014
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Revisiting lab-on-a-chip technology for drug discovery.Nature reviews. Drug discovery · 2012
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Humanized mice with ectopic artificial liver tissues.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alice A ChenMassachusetts Institute of Technology, Cambridge, 02139, USA.
Gregory H Underhill
Sangeeta N Bhatia

Funding

Tyrosine Kinase Signaling in Cancer Cell MetabolismR01CA140515 · NCI · UNIVERSITY OF CHICAGO · PI Jing Chen · 2010 to 2026
$5.4M
Engineering Multifunctional NanoparticlesR01CA124427 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BHATIA, SANGEETA N. · 2006 to 2010
$4.7M
ROLE OF TISSUE MICRO ARCHITECTURE ON HEPATOCYTE FUNCTIONR01DK056966 · NIDDK · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI BHATIA, SANGEETA N. · 2000 to 2011
$2.4M
Howard Hughes Medical InstituteIntramural NIH HHS Z99 CA999999NCI NIH HHS R01 CA124427NCI NIH HHS R01 CA140515NIDDK NIH HHS R01 DK056966
6 · The paper itself

Abstract

Three-dimensional (3D) tissue models have significantly improved our understanding of structure/function relationships and promise to lead to new advances in regenerative medicine. However, despite the expanding diversity of 3D tissue fabrication methods, approaches for functional assessment have been relatively limited. Here, we describe the fabrication of microtissue (μ-tissue) suspensions and their quantitative evaluation with techniques capable of analyzing large sample numbers and performing multiplexed parallel analysis. We applied this platform to 3D μ-tissues representing multiple stages of liver development and disease including: embryonic stem cells, bipotential hepatic progenitors, mature hepatocytes, and hepatoma cells photoencapsulated in polyethylene glycol hydrogels. Multiparametric μ-tissue cytometry enabled quantitation of fluorescent reporter expression within populations of intact μ-tissues (n≥ 10²-10³) and sorting-based enrichment of subsets for subsequent studies. Further, 3D μ-tissues could be implanted in vivo, respond to systemic stimuli, retrieved and quantitatively assessed. In order to facilitate multiplexed 'pooled' experimentation, fluorescent labeling strategies were developed and utilized to investigate the impact of μ-tissue composition and exposure to soluble factors. In particular, examination of drug/gene interactions on collections of 3D hepatoma μ-tissues indicated synergistic influence of doxorubicin and siRNA knockdown of the anti-apoptotic gene BCL-XL. Collectively, these studies highlight the broad utility of μ-tissue suspensions as an enabling approach for high n, populational analysis of 3D tissue biology in vitro and in vivo.

Indexed as

Animalsbcl-X ProteinBiocompatible MaterialsCell Culture TechniquesCell DifferentiationCell SurvivalCombined Modality TherapyDoxorubicinDoxycyclineEmbryonic Stem CellsFemaleFibroblastsFlow CytometryFluorescent DyesGene ExpressionGenes, ReporterBCL2L1 protein, humanbcl-X ProteinBiocompatible MaterialsDoxorubicinDoxycyclineFluorescent DyesHMGB ProteinsHydrogelspoly(ethylene glycol)diacrylatePolyethylene GlycolsRNA, Small InterferingSox17 protein, mouseSOXF Transcription Factors

Identifiers

PMID20820630
PMCPMC4124885

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.